NCT00930176 - A Study Investigating Treatment Factor X in People With Factor X Deficiency | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 31, 2010

Primary Completion Date

November 30, 2013

Study Completion Date

November 30, 2013

Conditions

Factor X Deficiency

Interventions

BIOLOGICAL

Human Coagulation FACTOR X

Standard dose 25IU/kg to be administered at the Baseline Visit (1st PK assessment) and at the repeat PK assessment. Also administered to treat a bleed or to prevent a bleed.

Trial Locations (14)

10065

Dr. William Mitchell New York Blood Center, Weill Cornell Medical College, New York

46260

Indiana Hemophilia & Thrombosis Center, Indianapolis

94117

UCSF School of Medicine, San Francisco

Unknown

Dr Gunter Auerswald, Bremen

Dr. Bermejo, Cáceres

Dr Maite Alvarez, Madrid

Cukurova University Hospital, Balcali

Ministry of Health Istanbul Goztepe Training & Research Hospital, Göztepe

Istanbul University Cerrahpasa School of Medicine, Istanbul

Kanuni Sultan Suleyman Training and Research Hospital, Istanbul

Prof. Kavakli, Izmir

Prof. Oner, Van

Dr. Sue Pavord, Leicester

Dr. Steve Austin, London